Literature DB >> 21515799

Illustration of SSMD, z score, SSMD*, z* score, and t statistic for hit selection in RNAi high-throughput screens.

Xiaohua Douglas Zhang1.   

Abstract

Hit selection is the ultimate goal in many high-throughput screens. Various analytic methods are available for this purpose. Some commonly used ones are z score, z* score, strictly standardized mean difference (SSMD), SSMD*, and t statistic. It is critical to know how to use them correctly because the misusage of them can readily produce misleading results. Here, the author presents basic concepts, elaborates their commonality and difference, describes some common misusage that people should avoid, and uses simulated simple examples to illustrate how to use them correctly.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21515799     DOI: 10.1177/1087057111405851

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  75 in total

1.  Automated selection of regions of interest for intensity-based FRET analysis of transferrin endocytic trafficking in normal vs. cancer cells.

Authors:  Ronak Talati; Andrew Vanderpoel; Amina Eladdadi; Kate Anderson; Ken Abe; Margarida Barroso
Journal:  Methods       Date:  2013-08-28       Impact factor: 3.608

2.  Defining a standard and weighted mathematical index for maturation of dendritic cells.

Authors:  Abdolamir Landi; Mohammad Tayfeh Aligodarzi; Ali Khodadadi; Lorne A Babiuk; Sylvia van Drunen Littel-van den Hurk
Journal:  Immunology       Date:  2017-11-24       Impact factor: 7.397

3.  High-Throughput Fluorescence-Based Screen Identifies the Neuronal MicroRNA miR-124 as a Positive Regulator of Alphavirus Infection.

Authors:  Paula López; Erika Girardi; Bryan C Mounce; Amélie Weiss; Béatrice Chane-Woon-Ming; Mélanie Messmer; Pasi Kaukinen; Arnaud Kopp; Diane Bortolamiol-Becet; Ali Fendri; Marco Vignuzzi; Laurent Brino; Sébastien Pfeffer
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

4.  Three-dimensional automated reporter quantification (3D-ARQ) technology enables quantitative screening in retinal organoids.

Authors:  M Natalia Vergara; Miguel Flores-Bellver; Silvia Aparicio-Domingo; Minda McNally; Karl J Wahlin; Meera T Saxena; Jeff S Mumm; M Valeria Canto-Soler
Journal:  Development       Date:  2017-09-04       Impact factor: 6.868

5.  Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy.

Authors:  Kristina J Allan; Douglas J Mahoney; Stephen D Baird; Charles A Lefebvre; David F Stojdl
Journal:  J Vis Exp       Date:  2018-04-03       Impact factor: 1.355

6.  Targeted genetic dependency screen facilitates identification of actionable mutations in FGFR4, MAP3K9, and PAK5 in lung cancer.

Authors:  Shameem Fawdar; Eleanor W Trotter; Yaoyong Li; Natalie L Stephenson; Franziska Hanke; Anna A Marusiak; Zoe C Edwards; Sara Ientile; Bohdan Waszkowycz; Crispin J Miller; John Brognard
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-08       Impact factor: 11.205

7.  High-Throughput RT-PCR for small-molecule screening assays.

Authors:  Joshua A Bittker
Journal:  Curr Protoc Chem Biol       Date:  2012-03-01

8.  Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infection.

Authors:  Najma Rachidi; Jean François Taly; Emilie Durieu; Olivier Leclercq; Nathalie Aulner; Eric Prina; Pascale Pescher; Cedric Notredame; Laurent Meijer; Gerald F Späth
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

Review 9.  Advances in zebrafish chemical screening technologies.

Authors:  Jonathan R Mathias; Meera T Saxena; Jeff S Mumm
Journal:  Future Med Chem       Date:  2012-09       Impact factor: 3.808

10.  Large-scale screening identifies a novel microRNA, miR-15a-3p, which induces apoptosis in human cancer cell lines.

Authors:  Aliaksandr Druz; Yu-Chi Chen; Rajarshi Guha; Michael Betenbaugh; Scott E Martin; Joseph Shiloach
Journal:  RNA Biol       Date:  2013-01-25       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.